NATURAL PRODUCT RESEARCH AND DEVELOPMENT ›› 2017, Vol. 29 ›› Issue (7): 1102-1106.doi: 10.16333/j.1001-6880.2017.7.004

• Article • Previous Articles     Next Articles

Effect of Pseudoprotodioscin on OX-LDL-induced COX-2 Expression in HUVEC

LI Di-di,CHEN Yang,TAN Wan-xian,ZOU Wen-jun*   

  1. Chengdu University of Traditional Chinese Medicine,Chengdu 610000,China
  • Online:2017-07-29 Published:2017-08-11

Abstract: Pseudoprotodioscinis the main active compound of Di’aoXinXue Kang capsules.To explore the effect of pseudoprotodioscin on cyclooxygenase-2 (COX-2) expression induced by OX-LDL in human umbilical vein endothelial cells (HUVEC),HUVEC cells were cultured in vitro. After pretreatment with different concentrations of pseudoprotodioscin for 24 h,OX-LDL was added for the induction of COX-2 expression.The expressions of COX-2 mRNA was detected by Real-time PCR,and the expression of COX-2 protein and the phosphorylation of mitogen activated protein kinase (MAPK) associated with COX-2 inflammatory signaling pathway were determined by Western blot.Our results showed that pseudoprotodioscin can inhibit OX-LDL-induced COX-2 expression in HUVEC dose-dependently,and inhibit TLR2 expression and p38MAPK activity.These results indicated that pseudoprodioscininhibited OX-LDL-induced COX-2 expression possibly via affecting the TLR2 / p38MAPK pathway,suggesting its anti-inflammatory effect on vein endothelial cells.

Key words: Pseudoprotodioscin, OX-LDL, human umbilical vein endothelial cells, cyclooxygenase-2, TLR2/P38MAPK pathway